Osteosarcoma: chemotherapy-induced changes at MR imaging
- PMID: 1535905
- DOI: 10.1148/radiology.182.3.1535905
Osteosarcoma: chemotherapy-induced changes at MR imaging
Abstract
Fifty-seven patients undergoing chemotherapy for osteosarcoma underwent evaluation with magnetic resonance (MR) imaging to identify changes related to a good or poor response. Spin-echo MR images obtained after preoperative chemotherapy were compared with images obtained before treatment. Histopathologic examination of each resected specimen was used to quantify the response. An increase in tumor volume and increased or unchanged edema were predictive of a poor histopathologic response (predictive values, 85%-92%). Decreased or unchanged tumor volume and a decrease in edema were poor predictors of a good response (predictive values, 56%-62%). Improved tumor demarcation, an increase in the size of areas of low signal intensity, and a decrease in joint effusion occurred independently of histopathologic response in almost half of the patients. With a subjective interpretation of MR images, poor respondents can be identified if an increase in tumor volume or no decrease in the amount of edema is seen. Subjective criteria do not contribute to the identification of good respondents.
Similar articles
-
[Osteosarcoma: magnetic resonance imaging of the effects of preoperative chemotherapy].Radiol Med. 1993 Jun;85(6):725-32. Radiol Med. 1993. PMID: 8337428 Italian.
-
Accuracy of MR imaging for estimating intraosseous extent of osteosarcoma.AJR Am J Roentgenol. 1996 Nov;167(5):1211-5. doi: 10.2214/ajr.167.5.8911182. AJR Am J Roentgenol. 1996. PMID: 8911182
-
The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas.AJR Am J Roentgenol. 1990 Apr;154(4):763-9. doi: 10.2214/ajr.154.4.2107673. AJR Am J Roentgenol. 1990. PMID: 2107673
-
[Role of chemotherapy in treatment of osteosarcoma].Pediatr Pol. 1995 Nov;70(11):939-47. Pediatr Pol. 1995. PMID: 8677160 Review. Polish.
-
Epigenetic changes in osteosarcoma.Bull Cancer. 2011 Jul;98(7):E62-8. doi: 10.1684/bdc.2011.1400. Bull Cancer. 2011. PMID: 21708514 Review.
Cited by
-
Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment.Pediatr Radiol. 2004 Aug;34(8):595-605. doi: 10.1007/s00247-004-1192-x. Epub 2004 Apr 22. Pediatr Radiol. 2004. PMID: 15103428 Review.
-
Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters.Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1842-53. doi: 10.1007/s00259-010-1484-3. Epub 2010 May 27. Eur J Nucl Med Mol Imaging. 2010. PMID: 20505933 Clinical Trial.
-
Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential ¹⁸F-FDG PET/CT and MRI.Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1553-62. doi: 10.1007/s00259-014-2746-2. Epub 2014 Mar 21. Eur J Nucl Med Mol Imaging. 2014. PMID: 24652233
-
[Epitheloid osteosarcoma. Differential diagnostic problems].Langenbecks Arch Chir. 1995;380(6):354-8. doi: 10.1007/BF00207225. Langenbecks Arch Chir. 1995. PMID: 8559006 German.
-
The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient.Skeletal Radiol. 2010 Feb;39(2):141-6. doi: 10.1007/s00256-009-0830-7. Epub 2009 Nov 19. Skeletal Radiol. 2010. PMID: 19924412 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical